(Press-News.org) A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time, and an AI algorithm to enable autocontouring has been introduced. The study is published in the peer-reviewed journal AI in Precision Oncology. Click here to read the article now.
Sushil Beriwal, from Allegheny Health Network, and Varian, and coauthors, analyzed 108 patients with head and neck cancers. The automated nodal contours were evaluated using a 4-point scale: a score of 4 was clinically usable with no edits; a score of 3 required minor edits; a score of 2 required major edits; and a score of 1 required complete re-contouring of the region."
The mean score for autocontouring was 3.56 +/- .40.
“Overall, the AI segmented autocontouring performed well with significant time saving and were clinically usable with no or minor edits the majority of times,” concluded the investigators.”
“The recent findings underscore the efficiency and reliability of AI in enhancing radiotherapy planning for head and neck cancer. With autocontouring algorithms demonstrating clinically usable results in the majority of cases, we're at the brink of a major shift in treatment preparation. This advancement not only promises significant time savings for healthcare professionals but also opens the door to potentially more precise and patient-specific treatments. As we move forward, the integration of AI into oncological care represents a pivotal step towards more streamlined and effective patient care,” says Douglas Flora, MD, Editor-in-Chief of AI in Precision Oncology.
About the Journal
AI in Precision Oncology is the only peer-reviewed journal dedicated to the advancement of artificial intelligence applications in clinical and precision oncology. Spearheaded by Editor-in-Chief Douglas Flora, MD and supported by a diverse and accomplished team of international experts, the Journal provides a high-profile forum for cutting-edge research and frontmatter highlighting important research and industry-related advances rapidly developing within the field. For complete information, visit the AI in Precision Oncology website.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.
END
Evaluating AI-based nodal contouring in head and neck cancer
2024-02-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
The Lancet: Black women in the USA were murdered six times more often than White women between 1999 and 2020, state-level analysis indicates
2024-02-09
Analysis of racial disparities in US homicide rates indicates Black women were on average six times more likely to die by homicide than White women between 1999 and 2020.
Homicide rates among Black women were significantly higher than for White women in all 30 states analysed, with some evidence suggesting the biggest differences are in states with the highest racial inequities.
The greatest disparity in homicide rates was in Wisconsin in 2019-2020, when Black women were 20 times more likely to be ...
Study shows clinical benefit of new way of treating advanced ER+ breast cancer
2024-02-09
A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor has anti-tumour effects in oestrogen receptor positive breast cancer patients.
Lead author Professor Carlo Palmieri from the University of Liverpool and The Clatterbridge Cancer Centre NHS Foundation Trust, said: “These results are very encouraging – we have shown that in advanced/metastatic breast cancer ...
Repeat testing for pre-eclampsia does not lead to better outcomes for pregnant women, but a single test is still beneficial
2024-02-09
A single test to speed up diagnosis of a serious disease in pregnant women does not need to be repeated, new research has found.
Results from the PARROT-2 trial, published today in the Lancet by researchers from King’s College London and funded by Jon Moulton Charitable Trust, Tommy’s Charity and the National Institute for Health and Care Research, has ruled out the need for routine repeat placental growth factor-based testing (PIGF) for all women with suspected pre-eclampsia.
PARROT-2 is a large, multi-centre UK trial in 1,252 women ...
Industrial pollution leaves its mark in Mediterranean corals
2024-02-09
UCL Press Release
Under embargo until Friday 9 February, 00:01 UK time
Industrial pollution leaves its mark in Mediterranean corals
For the first time, pollutants from burning fossil fuels have been found embedded in corals, offering scientists a potential new tool to track the history of pollution, finds a new study led by UCL researchers.
The study, published in the journal Science of the Total Environment, identified carbon particles emitted by burning fossil fuels embedded in the corals of Illa Grossa Bay, off the Columbretes Islands in the Mediterranean Sea. Finding this type of pollution – known as fly-ash or spheroidal carbonaceous particles (SCPs) ...
Urgent call for antitrust measures to safeguard innovation in spatial biology
2024-02-09
Recent breakthroughs in spatial biology technology have transformed biomedical research; however, legal disputes are preventing small, innovative companies from advancing new technologies and ideas. Ongoing litigation poses a threat to the progress of even the most promising scientific technologies and the potential discoveries they could enable, according to the authors of the exclusive article titled “Sounding an Alarm Over Spatial Biology,” in Genetic Engineering and Biotechnology News (GEN). Click here to read the article ...
Pre-diabetes gets its due: New $1.2 million award aimed at early intervention and treatment
2024-02-09
SAN ANTONIO, Feb. 8, 2024 – More than one out of three people have pre-diabetes, characterized by abnormal blood sugar levels not yet in the diabetes range – and yet associated with significant increases in eye, kidney and neuropathic diseases, and risk of cardiovascular death.
Moreover, the number of people with the condition is expected to double by 2030, with prevalence substantially higher in minority populations, including Hispanics. Both pre-diabetes and diabetes are considered global epidemics.
As pre-diabetes largely is underdiagnosed and undertreated, ...
Celebrating excellence in anatomy: AAA awards distinguished members
2024-02-08
ROCKVILLE, MD – February 8, 2024 – The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients. Eighteen of the association’s 2,455 members have been selected because they advanced AAA’s values: community, respect, inclusion, integrity, and discovery.
The AAA awards program provides over $650,000 in awards, research grants, and scholarships annually. Many recipients go on to achieve significant success in their careers.
"We, as anatomy ...
Athira Pharma announces publication in Frontiers in Neuroscience highlighting therapeutic potential of ATH-1105 in amyotrophic lateral sclerosis (ALS)
2024-02-08
BOTHELL, WA, Feb. 8, 2024 — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced publication of research highlighting the neuroprotective and anti-inflammatory effects of ATH-1105 in preclinical models of amyotrophic lateral sclerosis (ALS). The original research article, “ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS,” authored by Berthiaume, A., and Reda, S., et al., was published ...
Sex hormones help gonorrhea fight off antimicrobials and antibiotics
2024-02-08
DURHAM, N.C. – You know that package warning that oral birth control won’t prevent STIs? Well in the case of gonorrhea, the sexually transmitted bacterium that causes the disease can use those hormones to help it resist antibiotic attacks.
Like many bacteria, this bug, Neisseria gonorrhoeae, is equipped with pumps to push the killing chemicals out of its cells. But what’s unique, according to a Duke and Emory study online this week in Nature Communications, is that the hormones of the human urogenital tract actually allow gonorrhea to make and use more of these pumps to fight intrinsic ...
45 finalists named for the 2024 Hertz Fellowships
2024-02-08
The Fannie and John Hertz Foundation today announced 45 finalists for the 2024 Hertz Fellowships in applied science, mathematics and engineering.
Selected from more than 860 applicants and representing 21 universities, the finalists advance to a culminating round of interviews for one of the most competitive and coveted doctoral fellowships in the nation. The 2024 class of Hertz Fellows will be announced in May.
Since 1963, the Hertz Foundation has granted fellowships empowering the nation’s most promising young ...